Concerta generics in 2005?
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson's guidance for earnings per share in 2002 - released in conjunction with the Guidant acquisition - assumes there will be generic competition for the methylphenidate formulation Concerta, the company recently told analysts. Concerta is sold by McNeil's sales force. Andrx' ANDA for a generic version of the drug has been held up by a petition filed by J&J in March, arguing that the agency should apply stricter bioequivalence standards to the product...